Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines

BACKGROUND: Paclitaxel is a microtubule-stabilizing drug that has been commonly used in treating cancer. Due to genetic heterogeneity within patient populations, therapeutic response rates often vary. Here we used the NCI60 panel to identify SNPs associated with paclitaxel sensitivity. Using the pan...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Eng, Lawson, Ibrahim-zada, Irada, Jarjanazi, Hamdi, Savas, Sevtap, Meschian, Mehran, Pritchard, Kathleen I, Ozcelik, Hilmi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3050680/
https://ncbi.nlm.nih.gov/pubmed/21314952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-4-18
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы